Have a personal or library account? Click to login
Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests Cover

Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests

By: G. Garratty  
Paid access
|Dec 2020

References

  1. Garratty G. Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematoiogy 1985;2:1-8.
  2. Garratty G, Petz LD. Drug-induced immune hemolytic anemia. Am J Med 1975;58:398-407.10.1016/0002-9343(75)90606-3
  3. Petz LD, Garratty G. Acquired immune hemolytic anemias. New York: Churchill Livingstone, 1980.
  4. Petz LD, Branch DR. Drug-induced immune hemolytic anemia. In: Chaplin H Jr, ed. Immune hemolytic anemias. New York: Churchill Livingstone, 1985:47-94.
  5. De Week AL. Studies on penicillin hypersensitivity. I. The specificity of rabbit “anti-penicillin” antibodies. Int Arch Allergy Appl Immunol 1962;21:20-37.10.1159/000229312
  6. De Week AL. Newer developments in penicillin immunochemistry. Int Arch Allergy Appl Immuno 1963;22:245-50.10.1159/000229368
  7. Levine BB, Ovary Z. Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzyl-penicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin. J Exp Med 1961;114:875-904.
  8. Levine BB, Price VH. Studies on the immunological mechanisms of penicillin allergy. II. Antigenic specificities of allergic wheal-and-flare skin responses in patients with histories of penicillin allergy. Immunology 1964;7:527-56.
  9. Levine BB, Redmond AP. Minor haptenic determinant-specific reagents of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 1969;35:445-55.10.1159/000230197
  10. Parker CW, Shapiro J, Kern M, et al. Hypersensitivity to penicillenic acid derivatives in human beings with penicillin allergy. J Exp Med 1962;115:821-38.10.1084/jem.115.4.821
  11. Parker CW, De Weck AL, Kern M, et al. The preparation and some properties of penicillenic acid derivatives relevant to penicillin hypersensitivity. J Exp Med 1962;115:803-19.10.1084/jem.115.4.821
  12. Siegel BB, Levine BB. Antigenic specificities of skin-sensitizing antibodies in sera from patients with immediate systemic allergic reactions to penicillin. J Allergy 1964;35:488-98.10.1016/0021-8707(64)90080-2
  13. Theil JA, Mitchell S, Parker CW. Specificity of hemagglutination reactions in human and experimental penicillin hypersensitivity. J Allergy 1964;35:399-424.10.1016/0021-8707(64)90067-X
  14. Levine BB, Fellner MJ, Levytska V. Benzylpenicillioyl specific serum antibodies to penicillin in man. I. Development of a sensitive hemagglutination assay method and haptenic specificities of antibodies. J Immunol 1965;96:701-18.
  15. Ackroyd JF. The pathogenesis of thrombocytopenic purpura due to hypersensitivity to Sedormid. Clin Sci 1949;7:249-85.
  16. Ackroyd JF. Immunological mechanisms in drug hypersensitivity. In: Gell PGH, Coombs RRA, and Lachmann PJ, eds. Clinical aspects of immunology. 3rd ed. Blackwell Scientific Publications, 1975.
  17. Salama A, Northoff H, Burkhardt H, Mueller-Eckhardt C. Carbimazole-induced immune haemolytic anemia: role of drug-red blood cell complexes for immunization. Br J Haematol 1988;68:479-82.10.1111/j.1365-2141.1988.tb04240.x3377989
  18. Levine BB, Redmond A. Immunochemical mechanisms of penicillin induced Coombs positivity and hemolytic anemia in man. Int Arch Allergy Appl Immunol 1967;31:594-7.10.1159/0002299066047940
  19. Molthan L, Reidenberg MM, Eichman MF. Positive direct Coombs’ tests due to cephalothin. N Engl J Med 1967;277:123-5.10.1056/NEJM196707202770303
  20. Spath P, Garratty G, Petz LD. Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol 1971;107:860-9.10.4049/jimmunol.107.3.860
  21. Ferrone S, Zanella A, Mercuriali F, Pizzi C. Some enzymatic and metabolic activities of normal human erythrocytes treated in vitro with cephalothin. Eur J Pharmacology 1968;4:211.10.1016/0014-2999(68)90179-9
  22. Sirchia G, Murcuriali F, Ferrone S. Cephalothin-treated normal red cells: a new type of PNH-like cells. Experientia 1968;24:495.10.1007/BF021444145674999
  23. Levine BB. Antigenicity and cross-reactivity of penicillins and cephalosporins (abstracts). J Infect Dis 1973;128:S364,S366.10.1093/infdis/128.Supplement_2.S3644582844
  24. Miyake Y, Ebata M. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins. J Antibiotics 1976;29:667-8.
  25. Ebata M, Miyake Y, Uchida J. A quantitative assay of covalently bound cephalosporin derivatives in cephalosporin-protein conjugates. J Antibiotics 1976;29:665-6.10.7164/antibiotics.29.66559725
  26. Schneider CH, De Week AL. A new chemical aspect of penicillin allergy: the direct reaction of penicillin with epsilon-amino-groups. Nature 1965;208:57-9.10.1038/208057a05887711
  27. Batchelor FR, Dewdney JM, Gazzard R. Penicillin allergy: the formation of the penicilloyl determinant. Nature 1965;206:362-3.10.1038/206362a05835701
  28. Jamin D, Demers J, Shulman I, Lam HT, Momparler R. An explanation for nonimmunologic adsorption of proteins onto red blood cells: Schiff’s base reactions. Blood 1986;67:993-6.10.1182/blood.V67.4.993.993
  29. Jamin D, Shulman I, Lam HT, et al. Production of a positive direct antiglobulin test due to Suramin. Arch Pathol Lab Med 1988;112:898-900.
  30. Zeger G, Smith L, McQuiston D, Goldfinger D. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 1988;28:493-5.10.1046/j.1537-2995.1988.28588337345.x3420679
  31. Getaz EP, Beckley S, Fitzpatrick J, Dozier A. Cisplatin-induced hemolysis. N Engl J Med 1980;302:334-5.10.1056/NEJM1980020730206077188625
  32. Levi JA, Aroney RS, Dalley DN. Haemolytic anemia after cisplatin treatment. Br Med J 1981;282:2003-4.10.1136/bmj.282.6281.200315059586788166
  33. Christie DJ, Mullen PC, Aster RH. FAB-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985;75:310-4.10.1172/JCI1116914234423871201
  34. Smith ME, Reid DM, Jones CE, Jordon JV, Kautz CA, Shulman NR. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest 1987;79:912-7.10.1172/JCI1129014242353818954
  35. Habibi B. Drug induced red blood cell autoantibodies co-developed wtih drug specific antibodies causing haemolytic anemias. Br J Haematol 1985;61:139-43.10.1111/j.1365-2141.1985.tb04069.x2864949
  36. Salama A, Mueller-Eckhardt C. Rh blood group specific antibodies in immune hemolytic anemia induced by nominfensine. Blood 1986;68:1285-8.10.1182/blood.V68.6.1285.1285
  37. Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987;69:1006-10.10.1182/blood.V69.4.1006.1006
  38. Salama A, Gottsche B, Schleiffer T, Mueller-Eckhardt C. ‘Immune complex’ mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody. Transfusion 1987;27:460-3.10.1046/j.1537-2995.1987.27688071694.x3500531
  39. Shulman I, Arndt P, McGehee W, Garratty G. Cefotaxime-induced immune hemolytic anemia associated with antibody reacting by both the drug-adsorption and immune complex mechanisms (abstract). Transfusion 1988;28:35S.
  40. Postoway N, Schwellenbach J, McMahill PC, Garratty G. A fatal case of cephalosporin-induced immune hemolytic anemia with clinical and serological characteristics usually associated with an immune-complex mechanism (abstract). Transfusion 1988;28:35S.
  41. Donowitz GR, Mandel GL. Beta-lactam antibiotics. N Engl J Med 1988;318:490-500.10.1056/NEJM1988022531808063277054
  42. Kirtland HH, Mohler DN, Horwitz DA. Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. N Engl J Med 1980;302:825-32.10.1056/NEJM1980041030215026244489
  43. Garratty G, Arndt P, Prince H, Shulman I. In vitro IgG production following preincubation of lymphocytes with methyldopa and procainamide (abstract). Blood 1986;68:108a.
  44. Kelton JG. Impaired reticuloendotheilial function in patients treated with methyldopa. N Engl J. Med 1985;313:596-600.10.1056/NEJM1985090531310024022046
  45. Muirhead EE, Groves, M, Guy R, Halden ER, Bass RK. Acquired hemolytic anemia, exposure to insecticides and positive Coombs test dependent on insecticide preparations. Vox Sang 1959;4:277-92.10.1111/j.1423-0410.1959.tb03629.x14425063
  46. Garratty G, Houston M, Petz LD, Webb M. Acute immune intravascular hemolysis due to hydrochlorothiazide. Am J Clin Pathol I98l;76:73-«10.1093/ajcp/76.1.737258154
  47. Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Imune hemolytic anemia associated with probenecid. Am J Clin Pathol 1985;84:391-4.10.1093/ajcp/84.3.3914036870
  48. Hart MN, Mesara BW. Phenacetin antibody crossreactive with autoimmune erythrocyte antibody. Am J Clin Pathol 1969;52:695-7.10.1093/ajcp/52.6.6955353837
  49. Florendo NT, MacFarland D, Painter M, Muirhead EE. Streptomycin-specific antibody coincident with a developing warm autoantibody. Transfusion 1980;20:662-8.10.1046/j.1537-2995.1980.20681057155.x7434449
  50. Habibi B, Lopez M, Serdaru M, et al. Immune hemolytic anemia and renal failure due to teniposide. N Engl J Med 1982;306:1091-2.10.1056/NEJM1982050630618067070405
  51. Salama A, Mueller-Eckhardt C. Two types of nomifensine-induced immune haemolytic anemias: drug-dependent sensitization and/or autoimmunization. Br J Haematol 1986;64:613-20.10.1111/j.1365-2141.1986.tb02217.x3790448
  52. Salama A, Mueller-Eckhardt C. Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cells. Br J Haematol 1987;66:263-6.10.1111/j.1365-2141.1987.tb01309.x3606962
DOI: https://doi.org/10.21307/immunohematology-2019-1075 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 97 - 106
Published on: Dec 27, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 G. Garratty, published by American National Red Cross
This work is licensed under the Creative Commons License.